Journal article · 2025 · Open access

“Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer

Shelagh M. Szabo, Sarah Walker, Evelyn Griffin, Aya McMillan, Robert Bick, Frances Simbulan, Eon Ting, Stephanie Leann Snow

Cancers, 17(19), 3260 · Published 8 October 2025 · DOI 10.3390/cancers17193260

Open PDFView at the publisherCite this paper

In brief

““Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer” is a 2025 journal article by Shelagh M. Szabo and 7 co-authors, published in Cancers. OpenAlex counts 1 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Cancers.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
0.36
References
36
Authors
8

Abstract

BACKGROUND/OBJECTIVES: In early-stage oncology clinical trials, the use of endpoints beyond overall survival (OS), including recurrence-free survival (RFS) or event-free survival (EFS), is becoming more common. To understand whether these outcomes are important to patients, this study explored the perceived value of non-OS endpoints among Canadians treated for early-stage cancer or with curative intent. METHODS: Canadians treated for early-stage breast, lung, or gastrointestinal cancer participated in semi-structured interviews. Participants provided perspectives on OS, RFS, disease-free survival (DFS), EFS, and pathological complete response (pCR) endpoints. Reflexive thematic analysis was used to explore patterns in responses and alignment of trial endpoints with patient treatment goals, priorities and preferences. RESULTS: The mean age of the 33 participants was 54.8 years, and 21 were female; 28 reported prior surgery, and 21 were also treated with chemotherapy (11 specified as neo-adjuvant; 9 specified adjuvant). All participants valued OS, and most viewed non-OS endpoints as reflective of their treatment priorities, including maintaining health-related quality of life and getting back to 'normal'. They also valued timely and equitable treatment access and equated having access to new treatments with better options. While participants considered efficacy data from clinical trials provided by non-OS endpoints sufficient to want access to new treatments, the relative importance of being disease- or recurrence-free versus maximizing length of life differed according to recurrence status, prognosis, cancer type and life stage. CONCLUSIONS: These findings support the relevance and importance of non-OS endpoints to Canadians with early-stage cancer and highlight participants' desire for rapid approval of treatments with demonstrated improvements in non-OS endpoints.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Szabo, S. M., Walker, S., Griffin, E., McMillan, A., Bick, R., Simbulan, F., Ting, E., & Snow, S. L. (2025). “Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer. Cancers, 17(19), 3260. https://doi.org/10.3390/cancers17193260

MLA 9

Szabo, Shelagh M., et al. ““Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer.” Cancers, vol. 17, no. 19, 2025, p. 3260. https://doi.org/10.3390/cancers17193260.

Chicago

Szabo, Shelagh M., Sarah Walker, Evelyn Griffin, Aya McMillan, Robert Bick, Frances Simbulan, Eon Ting, and Stephanie Leann Snow. 2025. ““Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer.” Cancers 17 (19): 3260. https://doi.org/10.3390/cancers17193260.

Harvard

Szabo, S. M. et al. (2025) ‘“Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer’, Cancers, 17(19), p. 3260. doi:10.3390/cancers17193260.

IEEE

S. M. Szabo et al., ““Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer,” Cancers, vol. 17, no. 19, p. 3260, 2025, doi: 10.3390/cancers17193260.

BibTeX

@article{szabo2025just,
  title     = {{“Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer}},
  author    = {Szabo, Shelagh M. and Walker, Sarah and Griffin, Evelyn and McMillan, Aya and Bick, Robert and Simbulan, Frances and Ting, Eon and Snow, Stephanie Leann},
  journal   = {Cancers},
  year      = {2025},
  volume    = {17},
  number    = {19},
  pages     = {3260},
  doi       = {10.3390/cancers17193260},
  url       = {https://doi.org/10.3390/cancers17193260}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials

  • early-stage cancer
  • clinical trial endpoints
  • overall survival
  • recurrence-free survival
  • event-free survival
  • disease-free survival
  • pathological complete response
  • patient perspectives

Work with this paper

Most-cited papers in Mathematics

All highly cited Mathematics papers

Questions about this paper

How do I cite this paper in APA style?

Szabo, S. M., Walker, S., Griffin, E., McMillan, A., Bick, R., Simbulan, F., Ting, E., & Snow, S. L. (2025). “Are You Just Looking to ‘Survive’?”: A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer. Cancers, 17(19), 3260. https://doi.org/10.3390/cancers17193260

How many times has this paper been cited?

1 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cancers: sign in and open the PDF from this page.

Who wrote this paper?

Shelagh M. Szabo, Sarah Walker, Evelyn Griffin, Aya McMillan, Robert Bick, Frances Simbulan, Eon Ting, Stephanie Leann Snow.

What is the DOI of this paper?

10.3390/cancers17193260, permanently at https://doi.org/10.3390/cancers17193260. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.